Sort   by:  
 Page size 
UnknownThe respiratory syncytial virus prefusion F protein vaccine attenuates the severity of respiratory syncytial virus-associated disease in breakthrough infections in adults ≥60 years of age.
Not available
S-EPMC10837780 | biostudies-literature
GenomicsMELARISK_SNP_MITF_geno
Genotypes at MITF E318K variant
EGAD00000000122 | EGA
GenomicsMELARISK_MITF_geno
Genotypes at MITF E318K variant
EGAD00000000121 | EGA
GenomicsA MITF germline mutation predisposes to melanoma and renal cell carcinoma
Study EGAS00000000048
EGAS00000000048 | EGA
GenomicsMELARISK Data Access Committee
Access to data generated by the MELARISK is available by emailing application to the data access committee and will be granted to qualified investigators for appropriate use.
EGAC00000000016 | EGA
UnknownThe contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma.
Not available
S-EPMC2480975 | biostudies-literature
UnknownRespiratory Syncytial Virus Prefusion F Protein Vaccine Is Efficacious in Older Adults With Underlying Medical Conditions.
Not available
S-EPMC10810713 | biostudies-literature
UnknownEfficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons.
Not available
S-EPMC11175669 | biostudies-literature
UnknownCommon variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Not available
S-EPMC2893806 | biostudies-literature
UnknownPathway-based analysis of a melanoma genome-wide association study: analysis of genes related to tumour-immunosuppression.
Not available
S-EPMC3246481 | biostudies-literature
Sort   by:  
 Page size